Omada Health Guides to 20%+ Annual Revenue Growth
OMDA has more than doubled off its 52-week low of $10.28.
Summary
Omada Health management stated they see continued annual revenue growth of at least 20%. The company reported Q2 2026 revenue of $87.8M, up 43% YoY. Omada Health also sees an adjusted EBITDA margin of 30%. The company will present updated long-term financial targets at its inaugural investor day. No specific timeframe was given for how long the 20% growth rate is expected to persist. The stock is up modestly on the news.
At the time of this announcement, OMDA was trading at $21.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $10.28 to $26.92. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.